Takeda and BIRAC Join Hands To Foster Healthcare Innovation

Takeda announced the signing of a three-year Memorandum of Understanding (MOU) with the Biotechnology Industry Research Assistance Council (BIRAC), a public-sector business established by the Government of India's Department of Biotechnology.

The MoU was announced in the presence of Dr Jitendra Singh, Union Minister of State for Science & Technology, Minister of State for the Prime Minister Office, Government of India, and senior government and industry leaders. The partnership will allow Takeda to extend advisory and mentoring support to innovators and entrepreneurs while assisting them from ideation to market deployment of new-age healthcare solutions, as per economictimes. 

Speaking of the collaboration, Sanjay Patel, Global Head of Data Digital and Technology Innovation Capability Solutions, Takeda Pharmaceuticals International AG, said, “India is one of the most vibrant and promising healthcare markets. The country’s healthcare segment offers an incredible opportunity both for innovation and growth. This partnership between Takeda and BIRAC, thus, moves beyond convention, signifying a promise to further healthcare in a manner that sets the stage for lasting improvements in the years to come”.

The collaboration was launched during the Global Bio-India (GBI) 2023 event, which was put on by the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India, and its Public Sector Undertaking, BIRAC.

Takeda Pharmaceutical corporation Limited is a Japanese global pharmaceutical corporation with partial roots in the United States and the United Kingdom. It is Asia's largest pharmaceutical firm and one among the top 20 pharmaceutical businesses in the world in terms of sales.